TAS::75 0849::TAS SURVEILLANCE, EPIDEMIOLOGY AND END RESULTS PROGRAM

TAS::75 0849::TAS 监测、流行病学和最终结果计划

• 批准号: 8163652
• 负责人: CHARLES WIGGINS
• 金额: $ 2.18万
• 依托单位: NEW MEXICO STATE DEPARTMENT OF HEALTH
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-09-30 至 2011-09-29
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8163652
• 关键词: SEER Program

The Surveillance, Epidemiology, and End Results (SEER) Program was established by the National Cancer Institute (NCI) to collect and report periodically on population-based cancer incidence and survival data. It is a core component of the NCI's surveillance activities which provide information used for planning cancer control and research programs, and for evaluating the impact of such programs on cancer rates. The SEER Program was initiated in 1972 in response to requirements of the National Cancer Program for assessing the magnitude of the cancer burden in the United States, and for identifying factors related to cancer risk and/or patient survival. Objectives of the SEER Program include: 1. Assemble and report, on a periodic basis, estimates of cancer incidence. 2. Monitor annual cancer incidence trends to identify unusual changes in specific forms of cancer occurring in population subgroups defined by geographic, demographic, and social characteristics. 3. Provide continuing information on changes over time in extent of disease at diagnosis, trends in therapy, and changes in cancer patient survival. 4. Identify the occurrence of possible iatrogenic cancers, i.e., cancers that are caused by cancer therapy. 5. Serve as a research resource to the National Cancer Institute, and conduct studies dealing with current cancer control issues as well as issues related to the operation of the SEER Program which may lead to improved and/or more cost-effective operating procedures.

国家癌症研究所（NCI）建立了监视，流行病学和最终结果（SEER）计划，以定期收集和报告基于人群的癌症发病率和生存数据。它是NCI监视活动的核心组成部分，该活动提供了用于计划癌症控制和研究计划的信息，并评估了此类计划对癌症率的影响。 SEER计划于1972年启动，以应对国家癌症计划的要求，以评估美国癌症负担的大小，并确定与癌症风险和/或患者生存有关的因素。 SEER计划的目标包括： 1。定期组装并报告癌症发病率。 2。监测年度癌症发病率趋势，以确定由地理，人口统计和社会特征定义的人群亚组发生的特定癌症形式的异常变化。 3。提供有关随着时间的变化的持续信息，诊断时疾病的程度，治疗趋势以​​及癌症患者存活的变化。 4.确定可能的医源性癌症的发生，即是由癌症治疗引起的癌症。 5。作为国家癌症研究所的研究资源，并进行有关当前癌症控制问题的研究以及与SEER计划的运作有关的问题，这可能会导致改善和/或更具成本效益的操作程序。